Earlier this year, researchers of Brigham and Women’s Hospital Harvard Medical School looked at clinical trials to show how six biologics, in particular, improve lung function; cut down on steroid use ...

Some treatments show potential for wider application. Biologic therapies are helping advance severe asthma management by ...

Emphysema did not significantly affect the response to systemic therapy in patients with severe asthma, according to a recent retrospective study. Early improvement was linked to lower baseline FEV1 ...

Severe asthma does not respond well to regular asthma treatments, such as inhaled corticosteroids and inhaled bronchodilator medications. Those with severe asthma usually find their symptoms ...

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

Asthma management in winter can be a challenge, but with the right tools, your symptoms will be better controlled. By getting ...

Over the past few weeks in Victoria and other parts of Australia, we've been seeing some wild and stormy weather.

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

It is currently used for the treatment of severe asthma. The ABRA trial has found a single dose can be more effective when injected at the point of exacerbation compared to steroid tablets.

The first new treatment for asthma in 50 years has been developed with “dramatic effects” for sufferers, Luke O’Neill has ...

A first treatment has been found for chronic asthma in 50 years and could be “game changing” in preventing deadly attacks. Scientists have discovered benralizumab could tackle suffocating ...